This study provides evidence demonstrating the tolerance-inducing ability of HO-1-expressing DCs, which may offer an experimental basis for the design of therapeutic strategy for allergic asthma as well as other inflammatory diseases. This evidence concerns the gene HMOX1 and allergic asthma.